A pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis?
Open Access
- 15 August 2014
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 18 (11) , 2189-2197
Abstract
Characteristics of heart failure with preserved ejection fraction (HFPEF) have not yet been fully understood. The objectives of this pilot study are to detect protein expression profile in the sera of HFPEF patients, and to identify potential biomarkers for the disease. Five hundred and seven proteins were detected in the sera of healthy volunteers and patients with either HFPEF or hypertension using antibody microarrays (three in each group). The results showed that the serum concentrations of 17 proteins (e.g. angiogenin, activin A and artemin) differed considerably between HFPEF and non‐HFPEF patients (hypertensive patients and healthy controls), while a protein expression pattern distinct from that in non‐HFPEF patients was associated with HFPEF patients. The up‐regulation of angiogenin in both HFPEF patients with LVEF ≥50% (P = 0.004) and a subset of HFPEF patients with LVEF = 41–49% (P < 0.001) was further validated in 16 HFPEF patients and 16 healthy controls. Meanwhile, angiogenin distinguished HFPEF patients from controls with a mean area under the receiver operating characteristic curve of 0.88 (P < 0.001) and a diagnostic cut‐off point of 426 ng/ml. Moreover, the angiogenin levels in HFPEF patients were positively correlated with Lg(N‐terminal pro‐B‐type natriuretic peptide, NT‐proBNP) (P < 0.001). In addition, high angiogenin level (≥426 ng/ml) was a predictor of all‐cause death within a short‐term follow‐up duration, but not in the longer term of 36 months. This pilot study indicates that the aforementioned 17 potential biomarkers, such as angiogenin, may hold great promise for both diagnosis and prognosis assessment of HFPEF.Keywords
Funding Information
- Ministry of Science and Technology of China (2006BAI01A04)
- National Natural Science Foundation of China (81170221)
- Shanghai Municipal Natural Science Foundation (13ZR1452500)
- Shanghai Municipal Education Commission (12ZZ002)
This publication has 37 references indexed in Scilit:
- Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectorisCardiovascular Diabetology, 2013
- Circulating angiopoietins and cardiovascular mortality in cardiogenic shockEuropean Heart Journal, 2013
- Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure, 2011
- Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic EnigmaCurrent Cardiovascular Risk Reports, 2011
- KATP channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapyCardiovascular Research, 2011
- Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction TrialJournal of Cardiac Failure, 2009
- Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection FractionCirculation, 2009
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004